˹. (OPK) Announcements /news-media/announcements/rss en-us https://d1io3yog0oux5.cloudfront.net/_b4e6ff6ef47dceb9694bce8228582222/opko/files/theme/images/logo-sm.png ˹. Logo Equisolve Investor Relations Suite <![CDATA[Extended-Release Calcifediol: A Data Journey From Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4660/pdf/VIF1140_CKD-MBD_ASN_2400x1200_v6.pdf Thu, 02 Nov 23 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4660/pdf/VIF1140_CKD-MBD_ASN_2400x1200_v6.pdf <![CDATA[Extended-Release Calcifediol Overcomes Impact of Low eGFR on Vitamin D Metabolism]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4659/pdf/ASN_2023_Poster_eGFR_Effect_on_Vitamin_D_Metabolism_25Oct2023_Rev2.pdf Thu, 02 Nov 23 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4659/pdf/ASN_2023_Poster_eGFR_Effect_on_Vitamin_D_Metabolism_25Oct2023_Rev2.pdf <![CDATA[ASN Kidney Week 2023 Poster Presentation - Control of Secondary Hyperparathyroidism with Extended-release Calcifediol is Associated with Slower CKD Progression]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4658/pdf/ASN_2023_LB_Poster_Rev_24Oct2023_Rev3.pdf Thu, 02 Nov 23 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4658/pdf/ASN_2023_LB_Poster_Rev_24Oct2023_Rev3.pdf <![CDATA[˹ Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases]]> /news-media/press-releases/detail/467/opko-health-acquires-modex-therapeutics-gains-proprietary Mon, 09 May 22 00:00:00 -0400 /news-media/press-releases/detail/467/opko-health-acquires-modex-therapeutics-gains-proprietary <![CDATA[ASN Kidney Week 2021 Oral abstract presentation- Initial Evaluation of High-Dose Extended-Release Calcifediol (ERC) in Patients with Stage 5 CKD on Hemodialysis (HD) ]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4656/pdf/Strugnell_et_al_Initial_Evaluation_of_ERC_in_HD_ASN_2021.pdf Fri, 05 Nov 21 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4656/pdf/Strugnell_et_al_Initial_Evaluation_of_ERC_in_HD_ASN_2021.pdf <![CDATA[Introduction of Scarlet Health™ In-˹ Diagnostic Service]]> /news-media/announcements/detail/4655/introduction-of-scarlet-health-in-home-diagnostic-service Wed, 13 Jan 21 00:00:00 -0500 /news-media/announcements/detail/4655/introduction-of-scarlet-health-in-home-diagnostic-service <![CDATA[NFL Profiles BioReference During Sunday Games]]> /news-media/announcements/detail/4654/nfl-profiles-bioreference-during-sunday-games Tue, 05 Jan 21 00:00:00 -0500 /news-media/announcements/detail/4654/nfl-profiles-bioreference-during-sunday-games <![CDATA[Pituitary Society Presentation - Update on Somatrogon Development for the Treatment of Growth Hormone Deficiency in Pediatric and Adult Subjects]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4653/pdf/Somatrogon_update_%28adult_and_pediatric_studies%29_v2.pdf Wed, 28 Oct 20 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4653/pdf/Somatrogon_update_%28adult_and_pediatric_studies%29_v2.pdf <![CDATA[Presentation by Dr. Cheri Deal at ENDO Online 2020]]> https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4652/pdf/ENDO_Final_Deal.pdf Mon, 08 Jun 20 00:00:00 -0400 https://d1io3yog0oux5.cloudfront.net/_bc1390da6e01ffff2e51e508bc876e0e/opko/db/561/4652/pdf/ENDO_Final_Deal.pdf <![CDATA[Replay of the Evercore ISI COVID Dx Webinar with OPKO and BioReference Senior Leadership]]> /news-media/announcements/detail/4651/replay-of-the-evercore-isi-covid-dx-webinar-with-opko-and-bioreference-senior-leadership Wed, 27 May 20 00:00:00 -0400 /news-media/announcements/detail/4651/replay-of-the-evercore-isi-covid-dx-webinar-with-opko-and-bioreference-senior-leadership